Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,870 signal articles · 241 in last 24h · 118,518 total before filter · latest 40m ago
241last 24h
1545last 7d
255● bullish (7d)
161● bearish (7d)
205publishers
AllMacro300Earnings622M&A99Regulatory24Product14Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
2 Reasons to Like LII (and 1 Not So Much)
StockStory8d agoneutral
2 Reasons to Like LII (and 1 Not So Much)

Over the last six months, Lennox’s shares have sunk to $437.64, producing a disappointing 17.3% loss - a stark contrast to the S&P 500’s 10.9% gain. This might have investors contemplating their next move.

Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?
Insider Monkey8d agobullish
Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?

Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS of $2.80 exceeding expectations by $0.30. Despite that, the stock plunged due to mounting concerns about slowing domestic procedure growth. Worldwide procedures, da Vinci and Ion […]

Retail traders just drew a line under Tesla’s sell-off
TheStreet8d agobearish
Retail traders just drew a line under Tesla’s sell-off

Tesla (TSLA) just reminded Wall Street that its retail investor base still has unusual power. Tesla shares surged about 6% last week, rebounding from three weeks of losses as retail investors aggressively bought the drop. Retail inflows were about $372 million during five trading days, compared ...

Trading Day: Strait talking
Reuters8d agoneutral
Trading Day: Strait talking

By Jamie McGeever ORLANDO, Florida, Aug 10 (Reuters) - Wall Street wobbled and oil prices leaped 5% on Monday, as hopes of a U.S.-Iran peace deal and reopening of the Strait of Hormuz faded, while

Rocket Lab’s (NASDAQ:RKLB) Q2 CY2026: Beats On Revenue, Provides Optimistic Revenue Guidance for Next Quarter
StockStory8d agobullish
Rocket Lab’s (NASDAQ:RKLB) Q2 CY2026: Beats On Revenue, Provides Optimistic Revenue Guidance for Next Quarter

Aerospace and defense company Rocket Lab (NASDAQ:RKLB) announced better-than-expected revenue in Q2 CY2026, with sales up 62% year on year to $234.1 million. On top of that, next quarter’s revenue guidance ($257.5 million at the midpoint) was surprisingly good and 7% above what analysts were expecting. Its GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
Insider Monkey8d agoneutral
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts’ average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised its guidance and stated that it is on track to meet […]

Rocket Lab Narrows Loss As Revenue Climbs
The Wall Street Journal8d agobullish
Rocket Lab Narrows Loss As Revenue Climbs

The launch and space systems company narrowed its loss and reported rising revenue as it ended its second quarter with a backlog of $2.36 billion, up 137% year-over-year.